There were 371 press releases posted in the last 24 hours and 172,145 in the last 365 days.

Global Point-of-Care Testing (POCT) Market – Trends and Forecast To 2024

#Global_Poct_Market

#Global_Poct_Market_Blog

#Global _POCT_Market

Global point-of-care testing market is expected to reach USD 38.2 billion by 2024 from USD 18.5 billion in 2016.

Global Point-Of-Care Testing Market is expected to reach USD 38.2 billion by 2024 from USD 18.5 billion in 2016 in the forecast period 2017-2024.
— Data Bridge Market Research
DALLAS, TEXAS, UNITED STATES, January 9, 2017 /EINPresswire.com/ -- Global Point-of-care Testing (POCT) Market Trends and Forecast to 2024 – By Product (Blood Glucose Testing Kits, Cardiometabolic Monitoring Kits, Infectious Disease Testing Kits, Cholesterol Testing Kits, Pregnancy & Fertility Tests Kits, Tumor/Cancer Markers, Urinalysis Testing Kits, Cholesterol Test Strips, Hematology Testing Kits, Drugs Of Abuse Testing Kits, Fecal Occult Testing Kits, Rapid Coagulation Testing Kits, & Others),By Prescription Mode (Prescription Based Testing & Over-The-Counter Testing),By Distribution Channel (Direct Tenders & Retail),By End User (Hospital, Clinics, Ambulatory Care, Home Healthcare, & Research Laboratory), By Geography (North America, Europe, Asia-Pacific, South America, Rest of the World)

The Global point-of-care testing market is segmented on the basis of product, prescription mode, distribution channel, end user and geography.

Based on geography the market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and rest of the world. The report of this market covers countries like U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Turkey, Japan, China, Singapore, Brazil, India, Russia, and South Africa.

For a Sample of the report: http://databridgemarketresearch.com/reports/global-point-care-testing-poct-market-trends-forecast-2024/

By Product type:
• Blood Glucose Testing Kits
• Cardiometabolic Monitoring Kits
• Infectious Disease Testing Kits
• Cholesterol Testing Kits
• Pregnancy & Fertility Tests Kits
• Tumor/Cancer Markers
• Urinalysis Testing Kits
• Cholesterol Test Strips
• Hematology Testing Kits
• Drugs Of Abuse Testing Kits
• Fecal Occult Testing Kits
• Rapid Coagulation Testing Kits
• Others

By Prescription Mode:
• Prescription Based Testing
• Over-The-Counter Testing

By End-User:
• Hospital, Clinics,
• Ambulatory Care
• Home Healthcare
• Research Laboratory

The global point-of-care testing market report contains an in-depth profiling of the key market players, along with the recent developments (New product launches, partnerships, agreements, collaborations, and joint ventures) and strategies adopted by them to sustain and strengthen their positions in the market.

Read More on the market trends of Global Point-Of-Care Testing (POCT) Market: http://databridgemarketresearch.com/point-of-care-testing-market-poised-grow-9-5-2017-2024/

The key players operating in this market are Abbott Laboratories, Inc., Roche Diagnostics Limited, Siemens AG, Beckman Coulter, Inc., Becton, Dickinson and Company, Johnson & Johnson, Alere Inc., Instrumentation Laboratory, PTS Diagnostics, Abaxis, Inc., Medtronic, Accriva Diagnostics, Opti Medical, Sienco, Inc., Alpha Scientific, AccuBioTech Co., Ltd., ACON Laboratories, Inc., Acrongenomics, bioMérieux, Biomerica, Inc., Atlas Genetics Ltd., Alfa Scientific Designs, Inc., Bio-Rad Laboratories, Inc., Medica Corporation, and Nova Biomedical among other vernacular players.

Shubham Dwivedi
Data Bridge Market Research Private Ltd.
+1-888-387-2818
email us here